Roots Analysis has announced the addition of “RNAi Therapeutics Market, 2021-2030” report to its list of offerings. The concept of RNA interference (RNAi) was identified in the 1980s. It is based on the selective silencing of specific sequences of mRNA, thereby, inhibiting the ability to translate into disease causing proteins. Significant advancements in the developmental pipeline...

The potential therapeutic applications of RNAi were realized almost immediately after the phenomenon was first described; over the years, developers have gradually progressed their proprietary drug candidates with cautious optimism   Roots Analysis is pleased to announce the publication of its recent study, titled, “RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA,...